Publications by authors named "P J Liwang"

The poxvirus-derived protein vCCI (viral CC chemokine inhibitor) binds almost all members of the CC chemokine family with nanomolar affinity, inhibiting their pro-inflammatory actions. Understanding the affinity and specificity of vCCI could lead to new anti-inflammatory therapeutics. CCL17, also known as TARC, is unusual among CC chemokines by having only micromolar binding to vCCI.

View Article and Find Full Text PDF

Although COVID-19 transmission has been reduced by the advent of vaccinations and a variety of rapid monitoring techniques, the SARS-CoV-2 virus itself has shown a remarkable ability to mutate and persist. With this long track record of immune escape, researchers are still exploring prophylactic treatments to curtail future SARS-CoV-2 variants. Specifically, much focus has been placed on the antiviral lectin Griffithsin in preventing spike protein-mediated infection via the hACE2 receptor (direct infection).

View Article and Find Full Text PDF

The SARS-CoV-2 virion has shown remarkable resilience, capable of mutating to escape immune detection and re-establishing infectious capabilities despite new vaccine rollouts. Therefore, there is a critical need to identify relatively immutable epitopes on the SARS-CoV-2 virion that are resistant to future mutations the virus may accumulate. While hACE2 has been identified as the receptor that mediates SARS-CoV-2 susceptibility, it is only modestly expressed in lung tissue.

View Article and Find Full Text PDF

The protein Griffithsin (Grft) is a lectin that tightly binds to high-mannose glycosylation sites on viral surfaces. This property allows Grft to potently inhibit many viruses, including HIV-1. The major route of HIV infection is through sexual activity, so an important tool for reducing the risk of infection would be a film that could be inserted vaginally or rectally to inhibit transmission of the virus.

View Article and Find Full Text PDF
Article Synopsis
  • Chemokines are crucial proteins in the immune system that help regulate inflammation by attracting leukocytes; targeting and inhibiting them is a key anti-inflammatory strategy.
  • The study describes a method for producing fluorescently labeled chemokines using recombinant DNA techniques and custom enzymes, which is cost-effective compared to commercial reagents.
  • The resulting fluorescent chemokine (vMIP-fluor) was successfully used in binding studies, showcasing its potential in anti-inflammatory therapies and demonstrating its effectiveness in competition assays with other chemokines.
View Article and Find Full Text PDF